ESC Premium Access

Infarct size in a rat model of STEMI is reduced by interleukin-6 trans-signalling blockade using sgp130fc but not an anti-IL6R monoclonal antibody

Topic: Inflammation and microcirculation

Congress Presentation

About the speaker

Doctor Marc Jonathan George

University College London, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

6 more presentations in this session

Impact of LR11 as residual risk on long term clinical outcomes in patients with coronary artery disease treated with statin after first percutaneous coronary intervention

Speaker: Doctor N. Takahashi (Tokyo, JP)


Activation of regulatory T cells in patients with myocardial infarction endows them with enhanced suppressive ability and pro-inflammatory phenotype and function

Speaker: Associate Professor I. Dumitriu (Birmingham, GB)


Inflammasome induced endothelial microparticles impair cellular function in human coronary arterial smooth muscle cells.

Speaker: Mr A. Ackerschott (Bonn, DE)


Markers of gut leakage are associated with cardiovascular events in a high-risk population

Speaker: Doctor A. Awoyemi (Oslo, NO)


Circulating interleukin-8 levels are associated with myocardial injury, left ventricular function and future clinical adverse events in patients with ST-elevation myocardial infarction.

Speaker: Doctor C. Shetelig (Oslo, NO)


Access the full session

CAD: role of inflammation and immunity

Speakers: Doctor M. George, Doctor N. Takahashi, Associate Professor I. Dumitriu, Mr A. Ackerschott, Doctor A. Awoyemi...

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb